Clinical Program Lead (CPL) - RLT Focus
About The Position
The Clinical Program Lead (CPL) provides strategic medical guidance and leads the development of experimental oncology agents in the TCO portfolio, beginning with PE / DC (Portfolio Entry / Drug Candidate) of preclinical development and continuing through TDP (Transition Decision Point). This role offers strategic medical and scientific leadership and expertise to all line functions on the project team for the development of new oncology agents (e.g., small molecules, biologics, radioligand therapies). The CPL creates clinical development strategies, integrating medical knowledge with the expertise of colleagues from various disciplines to optimize the clinical development strategy. While registration studies are not within the responsibility of TCO, the CPL must provide an early clinical development strategy that foresees and supports subsequent registration trials. The role involves leading Biomedical Research Early Program Teams (BPTs) and potentially multiple global project teams, integrating preclinical information, and interpreting its implications for clinical development. The CPL collaborates with clinical scientists to develop clinical protocols and necessary instruments, ensuring the safe, ethical, and efficient conduct of trials in compliance with GCP and Novartis SOPs. They will liaise with outside experts, investigators, and regulatory authorities, represent projects, and contribute to continuous improvement initiatives. Informal mentorship of less experienced CPLs may also be part of the role.
Requirements
- MD or DO degree
- Board-certification in an oncology specialty and PhD-level science are preferred
- Fluent English – Oral and written
- At least 2 years of pharmaceutical/biotech industry experience in oncology clinical trials plus the equivalent duration experience from an academic medical center. If limited or no Pharmaceutical industry experience, then comparable senior academic experience in translational oncology and clinical research
- Experience within RLT preferred
- Recognized as an expert in your field by external medical experts. External candidates have a substantial record of publication and international recognition
- Excellent interpretation of oncology preclinical data (molecular biology, pharmacology, pharmacokinetics, and toxicology)
- Strong knowledge of the application of PK/PD and biostatistics to clinical development and clinical trials
- Proven ability to analyze and interpret efficacy and safety data relating to oncology
- Knowledge of GCP and world-wide regulatory requirements for clinical trials and oncology
- Excellent medical/scientific writing skills
- Successful track record of strategic thinking
- Proven ability to develop and inspire project/line/matrix multidisciplinary teams in a global environment
- Excellent personal ethical integrity and a commitment to improving the outcomes for patients with malignancies
- Excellent written and oral English communication/presentation skills
- Strong office IT skills
Nice To Haves
- Experience within RLT preferred
Responsibilities
- Provides strategic medical and scientific leadership and expertise to all line functions on the project team for the development of new oncology agents (e.g., small molecules, biologics, radioligand therapies) that are in preclinical development, typically beginning at the PE / DC
- Creates clinical development strategies for new oncology agents within the PE/ DC to TDP timeframe.
- Delivers solutions within functions, across functions, and on global projects, developing independent approach to TCO strategy.
- Provide an early clinical development strategy that foresees and supports subsequent registration trials.
- Development of the Integrated Development Plan Approval (IDPA) in alignment with CPL Disease Area Leads (DALs), Development (DEV), Strategy & Growth (S&G), and Commercial teams
- Lead Biomedical Research Early Program Teams (BPTs) to enable the start of clinical development and continuing through clinical trials needed to support TDP.
- Integrates preclinical information (pharmacology, toxicology, and pharmacokinetics) and interprets implications for clinical development, as articulated in the Investigator’s Brochure and First-in-Human protocol
- Collaborates with clinical scientists to develop clinical protocols for TCO compounds and develop the instruments needed to implement, interpret and report them (e.g., case report forms, report and analysis plans, clinical study reports)
- Applies own medical knowledge to guide the safe, ethical and efficient conduct of the trials under own responsibility.
- Liaises with outside experts, investigators, and regulatory authorities in oncology, and represents own projects to those groups and authorities
- Writes and reviews abstracts/manuscripts etc. for presentation/publications at internal/external meetings
- Participates in task forces to support continuous improvement and other management objectives.
- May provide informal mentorship to less experienced CPLs
Benefits
- health, life and disability benefits
- a 401(k) with company contribution and match
- a variety of other benefits
- a generous time off package including vacation, personal days, holidays and other leaves
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
What This Job Offers
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree
